Biopeak Health Raises $3M to Build India’s Longevity and Preventive Health Platform
Investorsync desk1 min read
Deal sheet
$3M
- Stage
- Seed
- Sector
- HealthTech
- Announced
- 8 June 2025
Biopeak, a Bengaluru-based wellness and longevity startup, has raised $3 million in seed funding from CLAYPOND Capital (the family office of Ranjan Pai), Prashanth Prakash (Accel India), and NKSquared (investment arm of Nikhil Kamath, Zerodha co-founder).
Founded in 2024 by Rishi Pardal and Shiva Subramanian, Biopeak delivers personalised preventive health services through its own clinics, combining molecular diagnostics, imaging, and AI to detect early physiological changes and enhance long-term health outcomes.
The funds will be used to expand clinic operations across major Indian cities, strengthen its AI-powered diagnostic engine, and broaden its team of doctors, nutritionists, and therapists. Biopeak launched its first clinic in Bengaluru in March 2025, focusing on cellular health, early interventions, and high-precision care delivery.
The startup sits at the intersection of AI, preventive medicine, and geroscience, aiming to help Indians take control of their healthspan—not just lifespan—through data-driven action.
Backed by top-tier founders and investors shaping India’s healthcare and tech future, Biopeak is poised to lead the next wave of science-led wellness infrastructure in the country.
...
Source: company announcement. First posted on the Investorsync LinkedIn page.
From InvestorDB